CompaniesGlycoNex

GlycoNex

active
New Taipei City, Taiwan
Founded 2001
Website
About

Antibody Reagents

Areas of Focus

Categories

Non-PharmaceuticalAntibodyTaiwan
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

49

By Phase

PHASE1/PHASE2: 1PHASE1: 1

By Status

ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04250597
NCT04798235
Hover over trial bars to see details

Recent Trials

NCT04798235Collaborator
First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis
PHASE1/PHASE2Active, not recruiting
3 participants
Started: Mar 12, 2021 · Completed: Mar 12, 2027
NCT04250597Lead Sponsor
Study of GNX102 in Patients With Advanced Solid Tumors
PHASE1Terminated
46 participants
Started: Jul 29, 2020 · Completed: Jul 26, 2023
Locations (1)
Headquarters
New Taipei City, Taiwan
Map

Loading map...